Rob Bradley, Ph.D., is a scientist, entrepreneur, and professor whose work spans computational biology, RNA therapeutics, and data-driven drug discovery. He is Co-Founder and co-CEO of Synthesize Bio and also Co-Founder of Codify Therapeutics, where he is helping to drive innovation at the intersection of AI and therapeutic development. He serves as the Director of the Translational Data Science Integrated Research Center at Fred Hutch, where he also holds the McIlwain Family Endowed Chair and is a Full Professor. He completed his postdoctoral research at MIT and earned his Ph.D. in Biophysics from UC Berkeley.